BrightSpring Health Services, Inc. (NASDAQ: BTSG) is among the top 11 best performing IPOs in the past 2 years. After a strong second quarter, the company raised its revenue and adjusted EBITDA guidance, leading to an increase in analysts’ price targets. Revenue for Q2 2025 grew by 29% year-over-year to $3.1 billion, with Pharmacy Solutions revenue up by 32% and specialty scripts by 38%. Analysts like Deutsche Bank and Bank of America raised their price targets on BTSG stock. Since its IPO, BTSG has seen a notable 147.09% growth. The company specializes in providing home and community-based health and pharmacy services to individuals with complex health needs.

Read more at Yahoo Finance: BrightSpring Health Soars Post-IPO on Strong Earnings and Upbeat Analyst Targets